Annual Shareholders Equity
$24.75 M
+$62.54 M+165.49%
December 31, 2023
Summary
- As of March 13, 2025, CTCX annual stockholders equity is $24.75 million, with the most recent change of +$62.54 million (+165.49%) on December 31, 2023.
- During the last 3 years, CTCX annual shareholders equity has risen by +$54.33 million (+183.68%).
- CTCX annual shareholders equity is now at all-time high.
Performance
CTCX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$4.06 M
-$2.69 M-196.30%
September 30, 2024
Summary
- As of March 13, 2025, CTCX quarterly stockholders equity is -$4.06 million, with the most recent change of -$2.69 million (-196.30%) on September 30, 2024.
- Over the past year, CTCX quarterly shareholders equity has dropped by -$24.98 million (-119.43%).
- CTCX quarterly shareholders equity is now -102.60% below its all-time high of $156.19 million, reached on June 30, 2023.
Performance
CTCX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTCX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +165.5% | -119.4% |
| 3 y3 years | +183.7% | +89.2% |
| 5 y5 years | +183.7% | +89.2% |
CTCX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.5% | -102.6% | +89.2% |
| 5 y | 5-year | at high | +165.5% | -102.6% | +89.2% |
| alltime | all time | at high | +165.5% | -102.6% | +89.2% |
Carmell Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$4.06 M(+196.3%) |
| Jun 2024 | - | -$1.37 M(-1.4%) |
| Mar 2024 | - | -$1.39 M(-105.6%) |
| Dec 2023 | $24.75 M | $24.75 M(+18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $20.92 M(-86.6%) |
| Jun 2023 | - | $156.19 M(-513.3%) |
| Dec 2022 | -$37.79 M(+27.8%) | -$37.79 M |
| Dec 2021 | -$29.58 M | - |
FAQ
- What is Carmell Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Carmell Therapeutics?
- What is Carmell Therapeutics annual shareholders equity year-on-year change?
- What is Carmell Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly shareholders equity year-on-year change?
What is Carmell Therapeutics annual stockholders equity?
The current annual shareholders equity of CTCX is $24.75 M
What is the all time high annual shareholders equity for Carmell Therapeutics?
Carmell Therapeutics all-time high annual stockholders equity is $24.75 M
What is Carmell Therapeutics annual shareholders equity year-on-year change?
Over the past year, CTCX annual stockholders equity has changed by +$62.54 M (+165.49%)
What is Carmell Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CTCX is -$4.06 M
What is the all time high quarterly shareholders equity for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly stockholders equity is $156.19 M
What is Carmell Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CTCX quarterly stockholders equity has changed by -$24.98 M (-119.43%)